Home > Insider Trading > Filing (0001638599-18-000027)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1535955	Lipocine Inc.	LPCN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1237404	A Stephen Hill	C/O 675 Arapeen Drive Suite 202 Salt Lake City UT 84108		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-12-29	2,500	$0.00	6,500	No	4	M	Direct
Common Stock	Disposition	2017-12-29	1,250	$3.47	5,250	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2017-12-29	2,500	$0.00	2,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,500	2017-12-29	2027-01-25	No	4	M	Direct

Footnotes

Represents shares of Lipocine Inc. common stock ("LPCN Common Stock") acquired upon the vesting of restricted stock units (see footnote 4).
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Represents the weighted average price of shares sold at a price that ranged from $3.43-$3.54.
Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021.